• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性线粒体功能障碍与阿尔茨海默病和唐氏综合征痴呆的病因。

Systemic mitochondrial dysfunction and the etiology of Alzheimer's disease and down syndrome dementia.

机构信息

Mitochondrial and Molecular Medicine and Genetics, University of California Irvine, Irvine, CA, USA.

出版信息

J Alzheimers Dis. 2010;20 Suppl 2(0 2):S293-310. doi: 10.3233/JAD-2010-100351.

DOI:10.3233/JAD-2010-100351
PMID:20463402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4175722/
Abstract

Increasing evidence is implicating mitochondrial dysfunction as a central factor in the etiology of Alzheimer's disease (AD). The most significant risk factor in AD is advanced age and an important neuropathological correlate of AD is the deposition of amyloid-beta peptide (Abeta40 and Abeta42) in the brain. An AD-like dementia is also common in older individuals with Down syndrome (DS), though with a much earlier onset. We have shown that somatic mitochondrial DNA (mtDNA) control region (CR) mutations accumulate with age in post-mitotic tissues including the brain and that the level of mtDNA mutations is markedly elevated in the brains of AD patients. The elevated mtDNA CR mutations in AD brains are associated with a reduction in the mtDNA copy number and in the mtDNA L-strand transcript levels. We now show that mtDNA CR mutations increase with age in control brains; that they are markedly elevated in the brains of AD and DS and dementia (DSAD) patients; and that the increased mtDNA CR mutation rate in DSAD brains is associated with reduced mtDNA copy number and L-strand transcripts. The increased mtDNA CR mutation rate is also seen in peripheral blood DNA and in lymphoblastoid cell DNAs of AD and DSAD patients, and distinctive somatic mtDNA mutations, often at high heteroplasmy levels, are seen in AD and DSAD brain and blood cells DNA. In aging, DS, and DSAD, the mtDNA mutation level is positively correlated with beta-secretase activity and mtDNA copy number is inversely correlated with insoluble Abeta40 and Abeta42 levels. Therefore, mtDNA alterations may be responsible for both age-related dementia and the associated neuropathological changes observed in AD and DSAD.

摘要

越来越多的证据表明,线粒体功能障碍是阿尔茨海默病(AD)发病机制的一个核心因素。AD 的最重要的危险因素是年龄增长,AD 的一个重要神经病理学相关性是淀粉样β肽(Abeta40 和 Abeta42)在大脑中的沉积。唐氏综合征(DS)老年患者也常出现类似 AD 的痴呆,但发病更早。我们已经表明,体细胞线粒体 DNA(mtDNA)控制区(CR)突变会随着年龄的增长在有丝分裂后组织中积累,包括大脑,并且 AD 患者大脑中的 mtDNA 突变水平明显升高。AD 大脑中升高的 mtDNA CR 突变与 mtDNA 拷贝数的减少和 mtDNA L 链转录水平的降低有关。我们现在表明,mtDNA CR 突变会随着对照大脑的年龄增长而增加;它们在 AD 和 DSAD 患者的大脑中明显升高;并且 DSAD 大脑中增加的 mtDNA CR 突变率与 mtDNA 拷贝数和 L 链转录物减少有关。在 AD 和 DSAD 患者的外周血 DNA 和淋巴母细胞 DNA 中也观察到 mtDNA CR 突变率增加,并且在 AD 和 DSAD 大脑和血细胞 DNA 中也观察到独特的体细胞 mtDNA 突变,通常具有高异质性水平。在衰老、DS 和 DSAD 中,mtDNA 突变水平与β-分泌酶活性呈正相关,mtDNA 拷贝数与不溶性 Abeta40 和 Abeta42 水平呈负相关。因此,mtDNA 改变可能是导致与年龄相关的痴呆症以及 AD 和 DSAD 中观察到的相关神经病理学变化的原因。

相似文献

1
Systemic mitochondrial dysfunction and the etiology of Alzheimer's disease and down syndrome dementia.系统性线粒体功能障碍与阿尔茨海默病和唐氏综合征痴呆的病因。
J Alzheimers Dis. 2010;20 Suppl 2(0 2):S293-310. doi: 10.3233/JAD-2010-100351.
2
Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication.阿尔茨海默病患者的大脑中存在体细胞线粒体DNA控制区突变,这些突变会抑制线粒体的转录和复制。
Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10726-31. doi: 10.1073/pnas.0403649101. Epub 2004 Jul 9.
3
A mitochondrial etiology of Alzheimer and Parkinson disease.阿尔茨海默病和帕金森病的线粒体病因
Biochim Biophys Acta. 2012 May;1820(5):553-64. doi: 10.1016/j.bbagen.2011.08.008. Epub 2011 Aug 16.
4
Metabolic and Growth Rate Alterations in Lymphoblastic Cell Lines Discriminate Between Down Syndrome and Alzheimer's Disease.淋巴细胞系中的代谢和生长速率改变可区分唐氏综合征和阿尔茨海默病。
J Alzheimers Dis. 2017;55(2):737-748. doi: 10.3233/JAD-160278.
5
Microbleeds and Cerebral Amyloid Angiopathy in the Brains of People with Down Syndrome with Alzheimer's Disease.唐氏综合征合并阿尔茨海默病患者脑内微出血和脑淀粉样血管病。
J Alzheimers Dis. 2019;67(1):103-112. doi: 10.3233/JAD-180589.
6
Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome.淀粉样前体蛋白代谢改变与唐氏综合征中的线粒体功能障碍有关。
Neuron. 2002 Feb 28;33(5):677-88. doi: 10.1016/s0896-6273(02)00604-9.
7
Mitochondrial DNA copy numbers in pyramidal neurons are decreased and mitochondrial biogenesis transcriptome signaling is disrupted in Alzheimer's disease hippocampi.阿尔茨海默病海马体中锥体神经元的线粒体DNA拷贝数减少,线粒体生物发生转录组信号传导受到破坏。
J Alzheimers Dis. 2014;40(2):319-30. doi: 10.3233/JAD-131715.
8
Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's disease.唐氏综合征和散发性阿尔茨海默病中的淀粉样蛋白、tau 和细胞因子的血浆生物标志物。
Alzheimers Res Ther. 2019 Mar 21;11(1):26. doi: 10.1186/s13195-019-0477-0.
9
Genetic basis of Alzheimer's dementia: role of mtDNA mutations.
Genes Brain Behav. 2006;5 Suppl 2:92-107. doi: 10.1111/j.1601-183X.2006.00225.x.
10
Dynamics of plasma biomarkers in Down syndrome: the relative levels of Aβ42 decrease with age, whereas NT1 tau and NfL increase.唐氏综合征患者血浆生物标志物的动态变化:Aβ42 相对水平随年龄下降,而 NT1 tau 和 NfL 则增加。
Alzheimers Res Ther. 2020 Mar 19;12(1):27. doi: 10.1186/s13195-020-00593-7.

引用本文的文献

1
Mitochondrial Imbalance in Down Syndrome: A Driver of Accelerated Brain Aging?唐氏综合征中的线粒体失衡:加速大脑衰老的驱动因素?
Aging Dis. 2025 Apr 8. doi: 10.14336/AD.2025.0189.
2
The neuroimmune nexus: unraveling the role of the mtDNA-cGAS-STING signal pathway in Alzheimer's disease.神经免疫联系:揭示线粒体DNA-环鸟苷酸-腺苷酸合成酶-干扰素基因刺激蛋白信号通路在阿尔茨海默病中的作用
Mol Neurodegener. 2025 Mar 4;20(1):25. doi: 10.1186/s13024-025-00815-2.
3
Mitochondrial Dysfunction Correlates with Brain Amyloid Binding, Memory, and Executive Function in Down Syndrome: Implications for Alzheimer's Disease in Down Syndrome.

本文引用的文献

1
Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's.家族中有晚发性阿尔茨海默病病史的正常个体中纤维状淀粉样-β负担增加。
Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):5949-54. doi: 10.1073/pnas.0914141107. Epub 2010 Mar 15.
2
A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease.载脂蛋白 E4 等位基因多态性与阿尔茨海默病发病年龄的相关性研究
Pharmacogenomics J. 2010 Oct;10(5):375-84. doi: 10.1038/tpj.2009.69. Epub 2009 Dec 22.
3
Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice.
线粒体功能障碍与唐氏综合征患者的脑淀粉样蛋白结合、记忆及执行功能相关:对唐氏综合征患者阿尔茨海默病的启示
Brain Sci. 2025 Jan 28;15(2):130. doi: 10.3390/brainsci15020130.
4
Oocytes with impaired meiotic maturation contain increased mtDNA deletions.减数分裂成熟受损的卵母细胞含有更多的线粒体DNA缺失。
J Assist Reprod Genet. 2025 Mar;42(3):753-762. doi: 10.1007/s10815-025-03393-w. Epub 2025 Jan 25.
5
Mitochondrial DNA (mtDNA) as fluid biomarker in neurodegenerative disorders: A systematic review.线粒体DNA(mtDNA)作为神经退行性疾病中的液体生物标志物:一项系统综述。
Eur J Neurol. 2025 Jan;32(1):e70014. doi: 10.1111/ene.70014.
6
Cerebrovascular disease is associated with Alzheimer's plasma biomarker concentrations in adults with Down syndrome.脑血管疾病与唐氏综合征成年人的阿尔茨海默病血浆生物标志物浓度相关。
Brain Commun. 2024 Sep 25;6(5):fcae331. doi: 10.1093/braincomms/fcae331. eCollection 2024.
7
Biogenesis and secretion of mitovesicles, small extracellular vesicles of mitochondrial origin at the crossroads between brain health and disease.线粒体小泡的生物发生与分泌,线粒体起源的细胞外小泡在脑健康与疾病的交叉点上。
Curr Opin Physiol. 2024 Aug;40. doi: 10.1016/j.cophys.2024.100765. Epub 2024 Jun 11.
8
Mitovesicles secreted into the extracellular space of brains with mitochondrial dysfunction impair synaptic plasticity.分泌到线粒体功能障碍的大脑细胞外空间中的线粒体小泡会损害突触可塑性。
Mol Neurodegener. 2024 Apr 14;19(1):34. doi: 10.1186/s13024-024-00721-z.
9
Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease.神经变性中的氧化损伤:阿尔茨海默病发病机制和进展中的作用。
Physiol Rev. 2024 Jan 1;104(1):103-197. doi: 10.1152/physrev.00030.2022.
10
The synergistic ameliorative activity of peroxisome proliferator-activated receptor-alpha and gamma agonists, fenofibrate and pioglitazone, on hippocampal neurodegeneration in a rat model of insulin resistance.过氧化物酶体增殖物激活受体α和γ激动剂非诺贝特和吡格列酮对胰岛素抵抗大鼠模型海马神经退行性变的协同改善作用。
Ibrain. 2022 Aug 8;8(3):251-263. doi: 10.1002/ibra.12059. eCollection 2022 Fall.
淀粉样蛋白-β和tau 协同损害三转基因阿尔茨海默病小鼠的氧化磷酸化系统。
Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):20057-62. doi: 10.1073/pnas.0905529106. Epub 2009 Nov 6.
4
Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease.全基因组关联研究发现海马萎缩是阿尔茨海默病的新的易感基因的定量特征。
PLoS One. 2009 Aug 7;4(8):e6501. doi: 10.1371/journal.pone.0006501.
5
Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease.在阿尔茨海默病雌性小鼠模型中,线粒体生物能量缺乏先于阿尔茨海默病病理变化出现。
Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14670-5. doi: 10.1073/pnas.0903563106. Epub 2009 Aug 10.
6
Respiratory function decline and DNA mutation in mitochondria, oxidative stress and altered gene expression during aging.衰老过程中的呼吸功能衰退、线粒体DNA突变、氧化应激及基因表达改变。
Chang Gung Med J. 2009 Mar-Apr;32(2):113-32.
7
MTERF2 is a nucleoid component in mammalian mitochondria.线粒体转录终止因子2(MTERF2)是哺乳动物线粒体中的一种类核成分。
Biochim Biophys Acta. 2009 May;1787(5):296-302. doi: 10.1016/j.bbabio.2009.01.018. Epub 2009 Feb 3.
8
Oxidant-induced changes in mitochondria and calcium dynamics in the pathophysiology of Alzheimer's disease.氧化应激诱导的线粒体变化及钙动力学在阿尔茨海默病病理生理学中的作用
Ann N Y Acad Sci. 2008 Dec;1147:221-32. doi: 10.1196/annals.1427.038.
9
Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: implication in the pathogenesis of Alzheimer's disease.脑微血管中的动脉粥样硬化病变与线粒体DNA缺失:对阿尔茨海默病发病机制的影响。
Vasc Health Risk Manag. 2008;4(3):721-30. doi: 10.2147/vhrm.s2608.
10
Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age.人突变型APP/PS-1双敲入小鼠大脑中的氧化损伤与年龄的关系。
Free Radic Biol Med. 2008 Nov 15;45(10):1420-5. doi: 10.1016/j.freeradbiomed.2008.08.012. Epub 2008 Aug 16.